FR2362138B1 - - Google Patents

Info

Publication number
FR2362138B1
FR2362138B1 FR7711307A FR7711307A FR2362138B1 FR 2362138 B1 FR2362138 B1 FR 2362138B1 FR 7711307 A FR7711307 A FR 7711307A FR 7711307 A FR7711307 A FR 7711307A FR 2362138 B1 FR2362138 B1 FR 2362138B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7711307A
Other languages
French (fr)
Other versions
FR2362138A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/716,446 external-priority patent/US4052552A/en
Priority claimed from US05/716,449 external-priority patent/US4054737A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2362138A1 publication Critical patent/FR2362138A1/fr
Application granted granted Critical
Publication of FR2362138B1 publication Critical patent/FR2362138B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR7711307A 1976-08-20 1977-04-14 Analogues de thromboxane Granted FR2362138A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/716,446 US4052552A (en) 1976-08-20 1976-08-20 Thromboxane b analogs
US05/716,449 US4054737A (en) 1976-08-20 1976-08-20 Thromboxane B analogs

Publications (2)

Publication Number Publication Date
FR2362138A1 FR2362138A1 (fr) 1978-03-17
FR2362138B1 true FR2362138B1 (el) 1983-06-10

Family

ID=27109535

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7711307A Granted FR2362138A1 (fr) 1976-08-20 1977-04-14 Analogues de thromboxane

Country Status (4)

Country Link
JP (1) JPS5325515A (el)
DE (1) DE2715884A1 (el)
FR (1) FR2362138A1 (el)
GB (1) GB1534981A (el)

Also Published As

Publication number Publication date
FR2362138A1 (fr) 1978-03-17
JPS5325515A (en) 1978-03-09
DE2715884A1 (de) 1978-02-23
GB1534981A (en) 1978-12-06

Similar Documents

Publication Publication Date Title
CH637799B (el)
FR2362138B1 (el)
CS178379B1 (el)
CS173369B1 (el)
CH597415A5 (el)
DD125989A1 (el)
CH593347A5 (el)
CH594137A5 (el)
CH595819A5 (el)
CH596635A5 (el)
CH597285A5 (el)
CH597372A5 (el)
CH613774A5 (el)
CH614113A5 (el)
CH597999A5 (el)
CH599828A5 (el)
CH600922A5 (el)
CH601084A5 (el)
CH601568A5 (el)
CH601649A5 (el)
CH606475A5 (el)
CH603378A5 (el)
CH604989A5 (el)
CH605001A5 (el)
CH605052A5 (el)

Legal Events

Date Code Title Description
ST Notification of lapse